A carregar...
Safety and Tolerability of c-MET Inhibitors in Cancer
The role of aberrant hepatocyte growth factor receptor (c-MET, also known as tyrosine-protein kinase MET)/hepatocyte growth factor (HGF) signaling in cancer progression and invasion has been extensively studied. c-MET inhibitors have shown promising pre-clinical and early phase clinical trial anti-t...
Na minha lista:
| Publicado no: | Drug Saf |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7491978/ https://ncbi.nlm.nih.gov/pubmed/30649748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-018-0780-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|